MedPath

Ultrasonic Wound Debridement vs. Standard Sharp Debridement

Not Applicable
Completed
Conditions
Chronic Skin Ulcers
Registration Number
NCT01237392
Lead Sponsor
Calvary Hospital, Bronx, NY
Brief Summary

A single center, randomized, parallel, clinical outcome trial to compare the rate of healing in chronic wounds debrided with either high energy ultrasonic debridement (with cavitation) or standard of care sharp debridement.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Chronic wound needing debridement >3 cm2
  • Ulcer history >4mo
  • Adequate arterial blood flow (ABI>0.7)
  • Venous, Inflammatory, Pressure, Diabetic
Exclusion Criteria
  • Bleeding disorder
  • ABI<0.7
  • Uncontrolled diabetes
  • Taking systemic corticosteroids
  • Chemotherapy
  • Participating in another study
  • Treatment with Apligraft, Dermagraft, or Regranex within 90 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to complete wound closure12 and 24 weeks
Secondary Outcome Measures
NameTimeMethod
Relative rate of wound healing8, 12 and 24 weeks

Trial Locations

Locations (1)

Calvary Hospital Center for Curative and Palliative Wound Care

🇺🇸

Bronx, New York, United States

Calvary Hospital Center for Curative and Palliative Wound Care
🇺🇸Bronx, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.